|
Abstract:
We are pleased to be here today to discuss our past work on the Department of Defense's (DOD) anthrax vaccine immunization program. As you know, DOD regards the biological agent anthrax, an infectious disease that is 99- percent lethal if inhaled by unprotected humans, as the single greatest biological weapon threat to U.S. military forces. DOD considers vaccination one of the measures critical to protecting U.S. forces against such weapons. In December 1997, the Secretary of Defense announced a plan to immunize all active and reserve military personnel with a licensed anthrax vaccine. In August 1998, DOD began immunizing all 2.4 million U.S. military personnel-including all active and reserve personnel-against anthrax. Today we would like to provide a brief update on three key findings of our October 1999 report. The findings relate to vaccine supply, medical records, and efforts to educate service members about the program. We have also reviewed other aspects of the anthrax vaccine immunization program, including the safety and efficacy of the vaccine and the contracts with the manufacturer. Our related reports are listed in an attachment to this statement.
| Pages: |
9 |
| Report Date: |
13 APR 2000 |
| Report Number: |
A750673 |
Report Unavailable |
| This title is unavailable from Storming Media. We do not know when it might be available, if at all. We list the report on our site for bibliographic completeness, to help our users know what other work has been performed in this field. Please note that as with all titles on this site, we do not have contact information for any of the authors. Nor can we give any suggestions on how one might obtain this report. |
|
|
|
|
|
Keywords relating to this report:
Email This Abstract
